Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Bharat Biotech

COVID-19 situation under control but caution needed with changing virus: V.K. Paul

Country currently has good vaccine coverage, he says

The Hindu

Drugs Controller allows restricted emergency use of Covaxin for 6-12 years

DCGI (Drugs Controller General of India) gives restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years. More details on Dynamite News:

Dynamite News

Paving the way for a global malaria vaccine

Malaria impacts India more than anywhere else in southeast Asia, but relief could be on the way if the early promise of vaccines in development is fulfilled.

360info

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Ocugen Shares Are Trading Higher Today

Ocugen Inc (NASDAQ:OCGN) and Bharat Biotech have amended their co-development, supply, and commercialization agreement to expand Ocugen's exclusive territory to include the commercialization of Covaxin in Mexico. This gives Ocugen Covaxin commercialization rights for all of North America. Covaxin can be an ideal vaccination option for Mexico at this pandemic stage. As a whole…

Benzinga

Morning Digest | Four militants behind J&K targeted killings shot dead; Covaxin trials in U.S. put on hold, and more

A select list of stories to read before you start your day

The Hindu

Covaxin trials in U.S. put on hold

WHO had announced suspension of the vaccine supplies through UN procurement agencies

The Hindu

FDA Places Clinical Hold On Ocugen's Late-Stage COVID-19 Vaccine Trial

The

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Price mix-up mars COVID-19 precaution dose roll-out

Some hospitals opt to wait for clarity.

The Hindu

A pause to reflect: On WHO decision to recommend a pause in the supply of Covaxin

The Government and Bharat Biotech should strive for better communication on vaccine safety

The Hindu

Read Why Did WHO Suspend UN Supply of Bharat Biotech's Covaxin COVID-19 Vaccine

According to Reuters, the World Health Organization suspended the supply of Covaxin through UN agencies for the COVID-19 vaccine. WHO said it would allow the manufacturer to improve its facilities and address issues found in a WHO post-emergency use listing (EUL) inspection of Bharat Biotech's manufacturing. The details of what…

Benzinga

WHO pauses Covaxin supply via UN bodies

Hyderabad

The Hindu

Better to err on the side of caution to ensure public health during pandemic, TN tells SC

State says the vaccine mandate, issued through a circular in November last, is backed by law

The Hindu

Vaccination advisory group recommends Covishield second dose eight weeks after first

Government has to take the final call, says National Technical Advisory Group on Immunisation

The Hindu

Bharat Biotech defamation case: A day after court order, Wire says no notice yet

Vaccine maker Bharat Biotech has moved court against Wire over at least 14 reports on the company and its vaccine Covaxin in a Rs 100 crore defamation suit, legal news websites reported on Wednesday.

Newslaundry

Get all your
news in one place.

100’s of premium titles.
One news app.

The Hindu

Take down stories on Bharat Biotech, court tells The Wire

The order was pronounced in a ₹100-crore defamation suit the pharmacy giant filed against The Wire

Dynamite News

Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials

The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.

The Hindu

DCGI gives nod to Bharat Biotech for intranasal booster dose trials

Experts have noted that an intranasal vaccine as a booster will be easier to administer in mass vaccination drives.

The Hindu

Five from TS win Padma Awards

Bharat Biotech’s Dr. Krishna, Suchitra Ella top list from State

Get all your
news in one place.

100’s of premium titles.
One news app.

1 2

People

Elon Musk

20,867 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

United Nations

29,580 stories

Bharatiya Janata Party

World Health Organization

842 stories

World Health Organisation

Serum Institute of India

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.